Author:
Høilund-Carlsen Poul F.,Alavi Abass,Barrio Jorge R.,Castellani Rudolph J.,Costa Tommaso,Herrup Karl,Kepp Kasper P.,Neve Rachael L.,Perry George,Revheim Mona-Elisabeth,Robakis Nikolaos K.,Sensi Stefano L.,Vissel Bryce
Subject
Neurology,Molecular Biology,Aging,Biochemistry,Biotechnology
Reference14 articles.
1. Alzforum, 2023. Revised Again: Alzheimer's Diagnostic Criteria Get Another Makeover. Revised Again: Alzheimer's Diagnostic Criteria Get Another Makeover | ALZFORUM.
2. Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment;Camus;Eur. J. Nucl. Med. Mol. Imaging,2012
3. Amyloid PET: a questionable single primary surrogate efficacy measure on alzheimer immunotherapy trials;Høilund-Carlsen;J. Alzheimers Dis.,2022
4. FDG-PET versus amyloid-PET imaging for diagnosis and response evaluation in alzheimer's disease: benefits and pitfalls;Høilund-Carlsen;Diagn. (Basel),2023
5. A/T/N: an unbiased descriptive classification scheme for Alzheimer disease biomarkers;Jack;Neurology,2016